Page 7 - Flipbook

Overall Learning Objectives

At the conclusion of this program, participants should be able to:

• Recognize the DNA damage response (DDR) gene mutations that are involved in prostate cancer, and

their implications for therapy

• Integrate genetic testing for patients with prostate cancer into their clinical practice

• Describe the mechanism of action, efficacy, and safety of PARP inhibitors in order to employ these

agents for the treatment of prostate cancer with DDR mutations

• Explain the timing, monitoring, and management of adverse events

DDR, DNA damage response; PARP, poly(ADP-ribose) polymerase